Home/Filings/4/0001628280-25-010688
4//SEC Filing

Patel Chintu 4

Accession 0001628280-25-010688

CIK 0001723128other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 7:31 PM ET

Size

20.7 KB

Accession

0001628280-25-010688

Insider Transaction Report

Form 4
Period: 2025-03-03
Patel Chintu
DirectorCo-CEO
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2025-03-03+579,7101,092,276 total
  • Tax Payment

    Class A Common Stock

    2025-03-03$8.76/sh274,307$2,402,929817,969 total
  • Exercise/Conversion

    Class A Common Stock

    2025-03-04+92,592910,561 total
  • Tax Payment

    Class A Common Stock

    2025-03-04$8.84/sh46,528$411,308864,033 total
  • Exercise/Conversion

    Performance-Based Restricted Stock Units

    2025-03-03579,7100 total
    Class A Common Stock (579,710 underlying)
  • Award

    Performance-Based Restricted Stock Units

    2025-03-03+890,410890,410 total
    Class A Common Stock (890,410 underlying)
  • Award

    Restricted Stock Units

    2025-03-03+239,726239,726 total
    Class A Common Stock (239,726 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-0492,592277,778 total
    Class A Common Stock (92,592 underlying)
Holdings
  • Class A Common Stock

    (indirect: By Trust)
    24,753,252
Footnotes (9)
  • [F1]Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2022, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These units were certified as meeting the performance threshold that resulted in vesting of 100% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2025 and settled into shares of Class A Common Stock on a one -for-one basis. Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 2.
  • [F2]Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units.
  • [F3]Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issues was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 5
  • [F4]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  • [F5]Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
  • [F6]Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  • [F7]Represents a performance-based restricted stock unit grant of 445,205 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units will be deemed earned and vested when settled into shares of Class A Common Stock shortly after February 28, 2028, the last day of the performance period.
  • [F8]The restricted stock units vest in four equal annual installments beginning on March 3, 2026.
  • [F9]On March 4, 2024, the Reporting Person was granted 370,370 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

Issuer

Amneal Pharmaceuticals, Inc.

CIK 0001723128

Entity typeother

Related Parties

1
  • filerCIK 0001737428

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 7:31 PM ET
Size
20.7 KB